NIDAL KARIM AL-RAHAL, OULA ABDULLAH NAJIM, AHMED SHEMRAN ALWATAIFY, ISRAA MUSTAFA ALMUSAWI, AHMED IBRAHIM SHUKR, YASER SHANYOR ALSALMAN. Emicizumab Prophylaxis Every Four weeks among Hemophilia a with Inhibitors in Iraq, Multicenter Study. Journal for ReAttach Therapy and Developmental Diversities, [S. l.], v. 5, n. 2s, p. 477–482, 2022. DOI: 10.67145/jrtdd.v5i2s.170. Disponível em: https://jrtdd.com/index.php/journal/article/view/170. Acesso em: 11 sep. 2026.